Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Novartis DeutschlandNovartis Deutschland
VS
Ipca Laboratories LimitedIpca Laboratories Limited
Novartis Deutschland

Novartis Deutschland

Sophie-Germain Straße 10, Nürnberg, Bayern, 90443, DE

Last Update: 29/12/2025

View Profile
Between 750 and 799
http://www.novartis.de
756/1000Fair

Novartis ist ein führendes Pharmaunternehmen in Deutschland mit ca. 2.600 Mitarbeitenden an verschiedenen Standorten und mehr als 70.000 Mitarbeitenden weltweit. Wir sind angetrieben davon, Medizin neu zu denken, um das Leben von Menschen zu verbessern. Wir nutzen Wisse...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:442
Subsidiaries:43
12-month incidents
0
Known data breaches
0
Attack type number
0
Ipca Laboratories Limited

Ipca Laboratories Limited

125 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, IN, 400067

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.ipca.com/
768/1000Fair

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,559
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Novartis Deutschland

Novartis Deutschland

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Ipca Laboratories Limited

Ipca Laboratories Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Deutschland in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Ipca Laboratories Limited in 2026.

Incidents

Incident History - Novartis Deutschland (X = Date, Y = Severity)

Novartis Deutschland cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Ipca Laboratories Limited (X = Date, Y = Severity)

Ipca Laboratories Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Novartis Deutschland

Novartis Deutschland

Incidents
No explicit notable incidents reported.
Ipca Laboratories Limited

Ipca Laboratories Limited

Incidents
No explicit notable incidents reported.

FAQ

Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has the best AI Cybersecurity Score ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has experienced more cyber incidents in the past ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has experienced more cyber incidents this year ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has experienced at least one ransomware attack ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has experienced at least one data breach ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has experienced at least one targeted cyberattack ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has experienced at least one vulnerability ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one holds the most compliance certifications ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one holds the fewest compliance certifications ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has the most subsidiaries ?
Between Novartis Deutschland company and Ipca Laboratories Limited company, which one has the largest number of employees ?
Between Novartis Deutschland and Ipca Laboratories Limited, which company holds both SOC 2 Type 1 certifications ?
Between Novartis Deutschland and Ipca Laboratories Limited, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Novartis Deutschland or Ipca Laboratories Limited ?
Which company is PCI DSS compliant - Novartis Deutschland or Ipca Laboratories Limited ?
Between Novartis Deutschland and Ipca Laboratories Limited, which company complies with HIPAA regulations for healthcare data ?
Between Novartis Deutschland and Ipca Laboratories Limited, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-57100
SUMMARY

Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
REFERENCES
CVE-2026-54998
SUMMARY

Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-45499
SUMMARY

Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
REFERENCES
CVE-2026-41106
SUMMARY

Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.3)
CVSS3
Base Score: 9.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N
IMPACT SCORE
5.8
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-26145
SUMMARY

Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 4.8)
CVSS3
Base Score: 4.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
REFERENCES